ROMOSOZUMAB-AQQG

ROMOSOZUMAB-AQQG was reported 14247 times

ROMOSOZUMAB-AQQG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TARTRATE-RESISTANT ACID PHOSPHATASE INCREASED 6 0.3750
1 SERUM PROCOLLAGEN TYPE I N-TERMINAL PROPEPTIDE DECREASED 5 0.2632
2 BONE DENSITY ABNORMAL 463 0.1238
3 BONE METABOLISM BIOCHEMICAL MARKER INCREASED 3 0.1000
4 COMPUTERISED TOMOGRAM HEART ABNORMAL 6 0.0732
5 PSEUDARTHROSIS 13 0.0568
6 TOOTH RESORPTION 11 0.0519
7 OESOPHAGEAL CARCINOMA RECURRENT 4 0.0465
8 JAW CLICKING 9 0.0423
9 COMPRESSION FRACTURE 196 0.0365
10 FRACTURE 676 0.0357
11 VERTEBROPLASTY 15 0.0336
12 EXTRASKELETAL OSSIFICATION 6 0.0279
13 ATYPICAL FRACTURE 17 0.0276
14 OSTEOPOROSIS POSTMENOPAUSAL 4 0.0268
15 THORACIC VERTEBRAL FRACTURE 79 0.0267
16 RADIUS FRACTURE 60 0.0250
17 EXOSTOSIS OF JAW 12 0.0242
18 FEMORAL NECK FRACTURE 117 0.0228
19 ALBUMIN GLOBULIN RATIO DECREASED 5 0.0216
20 CALCIUM METABOLISM DISORDER 4 0.0214
21 DENTAL RESTORATION FAILURE 15 0.0208
22 SPINAL COMPRESSION FRACTURE 166 0.0201
23 LACK OF ADMINISTRATION SITE ROTATION 6 0.0197
24 LUMBAR VERTEBRAL FRACTURE 87 0.0190
25 FRACTURE PAIN 10 0.0186
26 MARASMUS 28 0.0184
27 ARTIFICIAL CROWN PROCEDURE 9 0.0183
28 APPLICATION SITE INDURATION 3 0.0176
29 SPINAL FRACTURE 335 0.0167
30 BLOOD PARATHYROID HORMONE INCREASED 45 0.0154
31 ULNA FRACTURE 15 0.0151
32 DENTAL CARE 28 0.0151
33 INTERCEPTED PRODUCT ADMINISTRATION ERROR 115 0.0150
34 FRACTURED SACRUM 18 0.0145
35 OSTEOPOROTIC FRACTURE 25 0.0130
36 DENTAL IMPLANTATION 21 0.0128
37 PHYSICAL DECONDITIONING 33 0.0128
38 ATYPICAL FEMUR FRACTURE 36 0.0127
39 RUPTURED CEREBRAL ANEURYSM 8 0.0124
40 TRAUMATIC FRACTURE 9 0.0122
41 CEREBRAL AMYLOID ANGIOPATHY 4 0.0121
42 PATHOLOGICAL FRACTURE 59 0.0116
43 PERIPROSTHETIC FRACTURE 4 0.0106
44 AVULSION FRACTURE 3 0.0105
45 PARATHYROIDECTOMY 5 0.0104
46 CEREBELLAR STROKE 4 0.0102
47 HUMERUS FRACTURE 49 0.0102
48 FEMUR FRACTURE 314 0.0101
49 BONE METABOLISM DISORDER 3 0.0100
50 ARTERY DISSECTION 4 0.0097
51 AORTIC DISSECTION 39 0.0094
52 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 4 0.0094
53 LOOSE TOOTH 30 0.0093
54 SARCOPENIA 4 0.0092
55 BLOOD CREATINE PHOSPHOKINASE DECREASED 3 0.0091
56 PELVIC FRACTURE 69 0.0089
57 HYPERAESTHESIA TEETH 11 0.0087
58 ISCHAEMIC CEREBRAL INFARCTION 10 0.0086
59 OPEN FRACTURE 4 0.0083
60 SACRAL PAIN 5 0.0082
61 ACETABULUM FRACTURE 3 0.0080
62 OPHTHALMIC MIGRAINE 5 0.0072
63 GROIN PAIN 63 0.0072
64 BLOOD CALCIUM DECREASED 79 0.0070
65 WRONG PRODUCT ADMINISTERED 47 0.0069
66 DROWNING 7 0.0069
67 OSTEOGENESIS IMPERFECTA 4 0.0069
68 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 224 0.0066
69 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 4 0.0065
70 STERNAL FRACTURE 8 0.0065
71 VITAMIN D INCREASED 4 0.0065
72 INJECTION SITE OEDEMA 11 0.0064
73 FRACTURED COCCYX 8 0.0063
74 BLOOD URIC ACID DECREASED 3 0.0062
75 SHOULDER FRACTURE 10 0.0061
76 BONE OPERATION 4 0.0061
77 GIANT CELL ARTERITIS 5 0.0060
78 BONE DENSITY DECREASED 188 0.0060
79 PATELLA FRACTURE 14 0.0060
80 OCCUPATIONAL EXPOSURE TO PRODUCT 38 0.0059
81 DYSLALIA 4 0.0055
82 BLOOD CALCIUM ABNORMAL 9 0.0054
83 TOOTH DISORDER 118 0.0053
84 EXTRADURAL HAEMATOMA 7 0.0053
85 FIBULA FRACTURE 15 0.0052
86 SPONDYLOLISTHESIS 9 0.0052
87 PERIODONTITIS 11 0.0051
88 POLYMYALGIA RHEUMATICA 16 0.0050
89 PRINZMETAL ANGINA 5 0.0050
90 HYPOCALCAEMIA 93 0.0049
91 LUMBAR SPINAL STENOSIS 14 0.0048
92 FRACTURE DELAYED UNION 4 0.0047
93 ENDODONTIC PROCEDURE 12 0.0047
94 TOOTH FRACTURE 52 0.0047
95 VASCULAR DEMENTIA 4 0.0046
96 CALCULUS URINARY 7 0.0045
97 CATARACT NUCLEAR 3 0.0045
98 AORTIC VALVE STENOSIS 8 0.0045
99 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 5 0.0045
100 ESSENTIAL HYPERTENSION 8 0.0044
101 HYPERPARATHYROIDISM 9 0.0044
102 CERVICAL VERTEBRAL FRACTURE 15 0.0043
103 PAIN IN JAW 122 0.0043
104 BILE DUCT CANCER 5 0.0042
105 MULTIPLE FRACTURES 69 0.0042
106 TOOTH EXTRACTION 52 0.0042
107 LACUNAR INFARCTION 10 0.0042
108 TEMPOROMANDIBULAR JOINT SYNDROME 11 0.0041
109 BRAIN CONTUSION 3 0.0041
110 PRODUCT STORAGE ERROR 357 0.0041
111 INJECTION SITE SWELLING 312 0.0041
112 DEVICE SAFETY FEATURE ISSUE 4 0.0041
113 TIBIA FRACTURE 19 0.0040
114 JAW DISORDER 22 0.0040
115 CEREBRAL INFARCTION 98 0.0040
116 WRIST FRACTURE 48 0.0040
117 LACK OF INJECTION SITE ROTATION 7 0.0040
118 INTRACRANIAL ANEURYSM 16 0.0040
119 SPINAL FUSION SURGERY 16 0.0039
120 TRANSIENT ISCHAEMIC ATTACK 133 0.0039
121 BRAIN STEM INFARCTION 4 0.0039
122 BRAIN NATRIURETIC PEPTIDE INCREASED 12 0.0039
123 BONE PAIN 228 0.0039
124 PRODUCT ADMINISTRATION INTERRUPTED 30 0.0038
125 BASAL GANGLIA HAEMORRHAGE 3 0.0037
126 HAEMORRHAGE SUBCUTANEOUS 13 0.0037
127 GINGIVAL DISORDER 14 0.0036
128 INJECTION RELATED REACTION 6 0.0036
129 HIP FRACTURE 115 0.0036
130 SPINAL OPERATION 44 0.0036
131 JOINT NOISE 7 0.0036
132 OSTEONECROSIS OF JAW 88 0.0036
133 INJECTION SITE WARMTH 73 0.0035
134 INJECTION SITE HYPERSENSITIVITY 11 0.0035
135 INJECTION SITE HYPOAESTHESIA 5 0.0035
136 NONINFECTIVE GINGIVITIS 5 0.0035
137 INCISION SITE PAIN 4 0.0034
138 GINGIVAL SWELLING 15 0.0034
139 BLOOD ALKALINE PHOSPHATASE INCREASED 84 0.0034
140 REHABILITATION THERAPY 13 0.0034
141 JOINT ARTHROPLASTY 6 0.0033
142 HIP SURGERY 18 0.0033
143 CEREBROVASCULAR DISORDER 10 0.0033
144 CARDIAC DEATH 4 0.0033
145 BLOOD CALCIUM INCREASED 29 0.0033
146 DENTAL OPERATION 8 0.0032
147 INJURY ASSOCIATED WITH DEVICE 66 0.0032
148 BONE GRAFT 3 0.0032
149 BLOOD ALKALINE PHOSPHATASE DECREASED 3 0.0032
150 INJECTION SITE INDURATION 41 0.0032
151 TROPONIN T INCREASED 4 0.0032
152 TOOTHACHE 57 0.0031
153 CLAVICLE FRACTURE 12 0.0031
154 HOSPITALISATION 481 0.0031
155 MEAN CELL VOLUME INCREASED 8 0.0031
156 ABDOMINAL WALL HAEMATOMA 6 0.0031
157 DISLOCATION OF VERTEBRA 7 0.0031
158 UPPER LIMB FRACTURE 61 0.0031
159 ANGINA PECTORIS 87 0.0030
160 INJECTION SITE INFLAMMATION 15 0.0030
161 MITRAL VALVE PROLAPSE 5 0.0030
162 DISCOURAGEMENT 7 0.0030
163 ORAL SURGERY 7 0.0030
164 CORONARY ARTERY STENOSIS 15 0.0030
165 INJECTION SITE URTICARIA 73 0.0030
166 INJECTION SITE MASS 110 0.0030
167 AUTONOMIC NEUROPATHY 3 0.0030
168 STRESS CARDIOMYOPATHY 17 0.0029
169 CAROTID ARTERIOSCLEROSIS 3 0.0029
170 VENOUS THROMBOSIS LIMB 6 0.0029
171 BONE MARROW OEDEMA 3 0.0029
172 BLOOD CHLORIDE INCREASED 5 0.0029
173 PERIODONTAL DISEASE 4 0.0029
174 SUDDEN DEATH 30 0.0028
175 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 7 0.0028
176 KYPHOSIS 5 0.0028
177 GLOMERULAR FILTRATION RATE ABNORMAL 4 0.0028
178 CEREBRAL ARTERY OCCLUSION 3 0.0028
179 CARDIAC VALVE DISEASE 16 0.0028
180 AMAUROSIS FUGAX 3 0.0028
181 THERAPY NON-RESPONDER 125 0.0028
182 JAW FRACTURE 6 0.0028
183 STRESS FRACTURE 15 0.0028
184 LUNG CANCER METASTATIC 8 0.0028
185 CARDIAC FAILURE 222 0.0028
186 SINUS NODE DYSFUNCTION 5 0.0027
187 OSTEOPOROSIS 110 0.0027
188 SPINAL STENOSIS 11 0.0027
189 GINGIVAL PAIN 21 0.0026
190 ADMINISTRATION SITE PAIN 3 0.0026
191 GINGIVAL RECESSION 5 0.0026
192 VASCULAR RUPTURE 4 0.0026
193 TOOTH INFECTION 34 0.0026
194 BLOOD PHOSPHORUS INCREASED 7 0.0026
195 MEDICAL DEVICE IMPLANTATION 4 0.0025
196 FALL 844 0.0025
197 UNDERWEIGHT 5 0.0025
198 SPINAL DISORDER 24 0.0025
199 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 43 0.0025
200 SPINAL PAIN 29 0.0025
201 INJECTION SITE DISCOMFORT 26 0.0025
202 BLOOD IMMUNOGLOBULIN G INCREASED 3 0.0025
203 BONE DISORDER 45 0.0025
204 ILL-DEFINED DISORDER 150 0.0025
205 RETINAL VEIN OCCLUSION 7 0.0024
206 INJECTION SITE ERYTHEMA 299 0.0024
207 ARTHROPOD STING 4 0.0024
208 VASCULAR OCCLUSION 5 0.0024
209 CARDIAC FAILURE CHRONIC 10 0.0023
210 BONE LOSS 35 0.0023
211 SERUM FERRITIN DECREASED 4 0.0023
212 MEDICAL DEVICE REMOVAL 4 0.0023
213 SUBDURAL HAEMATOMA 33 0.0023
214 HAEMORRHAGIC STROKE 18 0.0023
215 THYROIDECTOMY 4 0.0023
216 CAROTID ARTERY STENOSIS 8 0.0023
217 DEMENTIA 64 0.0023
218 RIB FRACTURE 47 0.0023
219 EMOTIONAL POVERTY 4 0.0023
220 HYPERCALCAEMIA 28 0.0023
221 SCOLIOSIS 14 0.0023
222 BLOOD LOSS ANAEMIA 5 0.0022
223 CARBON DIOXIDE INCREASED 3 0.0022
224 ARRHYTHMIA 102 0.0022
225 INJECTION SITE CELLULITIS 4 0.0022
226 PROTEIN TOTAL DECREASED 8 0.0021
227 ARTERIOSCLEROSIS CORONARY ARTERY 14 0.0021
228 CEREBELLAR HAEMORRHAGE 3 0.0021
229 DRUG EFFECT LESS THAN EXPECTED 31 0.0021
230 INJECTION SITE RASH 64 0.0021
231 LOWER LIMB FRACTURE 40 0.0021
232 ACUTE MYOCARDIAL INFARCTION 60 0.0020
233 ANGIOPLASTY 3 0.0020
234 FOOT FRACTURE 38 0.0020
235 FIBRIN D DIMER INCREASED 7 0.0020
236 INTERCEPTED PRODUCT STORAGE ERROR 7 0.0020
237 CARDIAC FAILURE ACUTE 13 0.0019
238 AORTIC ARTERIOSCLEROSIS 5 0.0019
239 INJECTION SITE PAIN 592 0.0019
240 UNEVALUABLE EVENT 145 0.0019
241 RENAL IMPAIRMENT 161 0.0019
242 ADVERSE REACTION 25 0.0019
243 FACIAL PARALYSIS 16 0.0019
244 BLOOD POTASSIUM ABNORMAL 5 0.0019
245 INTERVERTEBRAL DISC DISORDER 8 0.0019
246 COLON CANCER METASTATIC 3 0.0019
247 THERAPY INTERRUPTED 132 0.0018
248 SPINAL OSTEOARTHRITIS 16 0.0018
249 INJECTION SITE VESICLES 11 0.0018
250 INJECTION SITE REACTION 125 0.0018
251 CORONAVIRUS INFECTION 12 0.0018
252 PRODUCT COMMUNICATION ISSUE 16 0.0018
253 PARAESTHESIA ORAL 26 0.0018
254 TOOTH ABSCESS 18 0.0018
255 SUBARACHNOID HAEMORRHAGE 18 0.0018
256 PERIARTHRITIS 4 0.0018
257 OSTEOMYELITIS 31 0.0017
258 EMBOLIC STROKE 6 0.0017
259 ANGINA UNSTABLE 11 0.0017
260 INJECTION SITE DISCOLOURATION 21 0.0017
261 LIMB OPERATION 8 0.0017
262 AORTIC VALVE INCOMPETENCE 7 0.0016
263 PNEUMONIA ASPIRATION 41 0.0016
264 VITAMIN D DEFICIENCY 16 0.0016
265 BLOOD ALBUMIN DECREASED 13 0.0016
266 GLOMERULAR FILTRATION RATE DECREASED 20 0.0016
267 DENTAL CARIES 18 0.0016
268 ANKLE FRACTURE 25 0.0016
269 ARTHRALGIA 670 0.0016
270 INTRAVENTRICULAR HAEMORRHAGE 4 0.0016
271 POST PROCEDURAL INFECTION 13 0.0016
272 CHEMOTHERAPY 6 0.0016
273 RETINAL ARTERY OCCLUSION 4 0.0016
274 FACE INJURY 6 0.0016
275 INJECTION SITE PRURITUS 104 0.0016
276 BLOOD CHLORIDE DECREASED 4 0.0015
277 CARCINOEMBRYONIC ANTIGEN INCREASED 3 0.0015
278 AUTOIMMUNE DISORDER 15 0.0015
279 EXOSTOSIS 14 0.0015
280 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 4 0.0015
281 HYPOAESTHESIA ORAL 23 0.0015
282 EYE OPERATION 7 0.0015
283 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
284 LOCALISED OEDEMA 7 0.0015
285 CEREBRAL HAEMORRHAGE 54 0.0015
286 ANIMAL BITE 4 0.0015
287 BODY HEIGHT DECREASED 16 0.0015
288 CORONARY ARTERY THROMBOSIS 3 0.0015
289 GINGIVITIS 8 0.0015
290 COLITIS ISCHAEMIC 10 0.0015
291 TONGUE ULCERATION 5 0.0015
292 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 6 0.0015
293 TRIGGER FINGER 6 0.0015
294 MUSCULOSKELETAL DISCOMFORT 25 0.0015
295 RED BLOOD CELL COUNT INCREASED 4 0.0014
296 CHEST INJURY 3 0.0014
297 HIP ARTHROPLASTY 22 0.0014
298 AORTIC STENOSIS 5 0.0014
299 MYOCARDIAL ISCHAEMIA 16 0.0014
300 TOOTH LOSS 29 0.0014
301 METASTATIC NEOPLASM 6 0.0014
302 TOOTH DISCOLOURATION 4 0.0014
303 LYMPHOMA 21 0.0014
304 MUSCULOSKELETAL CHEST PAIN 21 0.0014
305 ATRIAL FIBRILLATION 132 0.0014
306 SENSITIVE SKIN 10 0.0014
307 VARICOSE VEIN 7 0.0014
308 CATARACT OPERATION 8 0.0013
309 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
310 ACCIDENT 16 0.0013
311 DIALYSIS 19 0.0013
312 NECK PAIN 74 0.0013
313 AUTOIMMUNE THYROIDITIS 5 0.0013
314 INGUINAL HERNIA 8 0.0013
315 BRAIN OPERATION 3 0.0013
316 LYMPHOEDEMA 9 0.0013
317 SURGERY 76 0.0013
318 DIASTOLIC DYSFUNCTION 4 0.0013
319 THERAPEUTIC PRODUCT INEFFECTIVE 5 0.0013
320 VITAMIN D DECREASED 11 0.0013
321 BRAIN FOG 20 0.0013
322 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
323 RETINAL HAEMORRHAGE 9 0.0013
324 ADVERSE EVENT 116 0.0013
325 TRICUSPID VALVE INCOMPETENCE 10 0.0013
326 BILE DUCT STONE 4 0.0013
327 ANGIOPATHY 7 0.0012
328 VITAMIN B12 DEFICIENCY 5 0.0012
329 ISCHAEMIC STROKE 22 0.0012
330 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 8 0.0012
331 ORAL DISORDER 9 0.0012
332 CARDIOVASCULAR DISORDER 31 0.0012
333 BLOOD SODIUM DECREASED 23 0.0012
334 CARTILAGE INJURY 3 0.0012
335 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
336 COLON CANCER 18 0.0012
337 SCIATICA 19 0.0012
338 AORTIC ANEURYSM 9 0.0012
339 SHOULDER OPERATION 5 0.0012
340 MYALGIA 198 0.0012
341 LOW DENSITY LIPOPROTEIN INCREASED 9 0.0012
342 PAIN IN EXTREMITY 340 0.0012
343 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
344 IMMOBILE 5 0.0011
345 MOBILITY DECREASED 82 0.0011
346 FACIAL PARESIS 4 0.0011
347 HAND FRACTURE 8 0.0011
348 KNEE OPERATION 11 0.0011
349 MONOCYTE COUNT INCREASED 4 0.0011
350 LIVER TRANSPLANT 4 0.0011
351 INTERVERTEBRAL DISC PROTRUSION 24 0.0011
352 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
353 FOOD INTOLERANCE 4 0.0011
354 HEMIPLEGIA 9 0.0011
355 ROSACEA 5 0.0011
356 PULMONARY ALVEOLAR HAEMORRHAGE 6 0.0011
357 PERIORBITAL SWELLING 6 0.0011
358 MITRAL VALVE INCOMPETENCE 12 0.0011
359 MYOCARDIAL INFARCTION 184 0.0011
360 BACK DISORDER 17 0.0010
361 HEAD INJURY 33 0.0010
362 THYROID MASS 4 0.0010
363 BRONCHIECTASIS 7 0.0010
364 PYELONEPHRITIS 9 0.0010
365 ATRIOVENTRICULAR BLOCK 8 0.0010
366 MUSCLE RUPTURE 4 0.0010
367 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 73 0.0010
368 BACK PAIN 238 0.0010
369 INJECTION SITE IRRITATION 13 0.0010
370 CHOLECYSTITIS 12 0.0010
371 CARDIAC PACEMAKER INSERTION 6 0.0010
372 ANEURYSM 5 0.0010
373 HYPERLIPIDAEMIA 12 0.0010
374 BONE MARROW DISORDER 3 0.0010
375 ARTHROPATHY 55 0.0010
376 OSTEOPENIA 15 0.0010
377 CORONARY ARTERIAL STENT INSERTION 5 0.0010
378 PRODUCT SUPPLY ISSUE 7 0.0010
379 CEREBROVASCULAR ACCIDENT 166 0.0010
380 PERIPHERAL VENOUS DISEASE 4 0.0010
381 PARALYSIS 14 0.0010
382 GOITRE 4 0.0010
383 PHLEBITIS 5 0.0010
384 OSTEONECROSIS 32 0.0010
385 TRISMUS 5 0.0010
386 CHOLANGITIS 6 0.0010
387 ACUTE CORONARY SYNDROME 8 0.0010
388 ILEUS 12 0.0010
389 APPENDICITIS 9 0.0010
390 ARTERIOSCLEROSIS 9 0.0010
391 KNEE ARTHROPLASTY 20 0.0009
392 BREAST CANCER RECURRENT 3 0.0009
393 JOINT DISLOCATION 10 0.0009
394 MUSCULOSKELETAL DISORDER 18 0.0009
395 OSTEOARTHRITIS 40 0.0009
396 TONGUE DISCOMFORT 4 0.0009
397 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 16 0.0009
398 CARDIAC FLUTTER 6 0.0009
399 PEMPHIGOID 7 0.0009
400 MUSCLE TIGHTNESS 15 0.0009
401 HYSTERECTOMY 8 0.0009
402 HYDROCEPHALUS 5 0.0009
403 DECREASED IMMUNE RESPONSIVENESS 9 0.0009
404 DEVICE PHYSICAL PROPERTY ISSUE 7 0.0009
405 APPETITE DISORDER 6 0.0009
406 GAIT INABILITY 30 0.0009
407 LIMB INJURY 24 0.0009
408 MUSCLE SPASMS 161 0.0009
409 ALTERED STATE OF CONSCIOUSNESS 19 0.0009
410 INJECTION SITE PAPULE 4 0.0009
411 ONYCHOCLASIS 6 0.0009
412 MOUTH SWELLING 5 0.0009
413 BLOOD CHOLESTEROL ABNORMAL 4 0.0009
414 HAEMATOCRIT DECREASED 17 0.0009
415 PALPITATIONS 100 0.0009
416 METASTASES TO BONE 14 0.0009
417 LEUKAEMIA 8 0.0008
418 DEEP VEIN THROMBOSIS 55 0.0008
419 CATARACT 50 0.0008
420 TENDONITIS 13 0.0008
421 FEEDING DISORDER 17 0.0008
422 BREAST CANCER METASTATIC 9 0.0008
423 PROTHROMBIN TIME PROLONGED 5 0.0008
424 THERAPY PARTIAL RESPONDER 13 0.0008
425 POST PROCEDURAL COMPLICATION 16 0.0008
426 HYPERCHOLESTEROLAEMIA 8 0.0008
427 FINGER DEFORMITY 4 0.0008
428 DIZZINESS POSTURAL 8 0.0008
429 PERIPHERAL SWELLING 127 0.0008
430 BURSITIS 10 0.0008
431 NEOPLASM MALIGNANT 55 0.0008
432 PRESYNCOPE 20 0.0008
433 INJECTION SITE NODULE 9 0.0008
434 AMYLASE INCREASED 3 0.0008
435 RASH PRURITIC 44 0.0008
436 MUSCLE STRAIN 7 0.0008
437 CARDIAC MURMUR 7 0.0008
438 LIMB DISCOMFORT 25 0.0008
439 PARAESTHESIA 127 0.0008
440 CARDIAC DYSFUNCTION 3 0.0008
441 MALNUTRITION 9 0.0008
442 LUNG NEOPLASM MALIGNANT 33 0.0008
443 HYPERNATRAEMIA 4 0.0008
444 ARTHRITIS 63 0.0008
445 VEIN DISORDER 4 0.0008
446 C-REACTIVE PROTEIN INCREASED 29 0.0008
447 REBOUND EFFECT 9 0.0008
448 HEADACHE 498 0.0008
449 PHOTOPSIA 5 0.0008
450 TROPONIN INCREASED 6 0.0008
451 LOSS OF CONSCIOUSNESS 101 0.0008
452 MASS 11 0.0008
453 EAR DISCOMFORT 8 0.0008
454 ROTATOR CUFF SYNDROME 10 0.0008
455 THYROID DISORDER 12 0.0008
456 CACHEXIA 4 0.0008
457 ILLNESS 79 0.0008
458 URTICARIA 128 0.0008
459 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 14 0.0008
460 PNEUMONIA BACTERIAL 7 0.0008
461 NERVE COMPRESSION 7 0.0008
462 DYSSTASIA 22 0.0008
463 EYE HAEMORRHAGE 10 0.0007
464 JOINT INJURY 16 0.0007
465 MENINGITIS 5 0.0007
466 OVERWEIGHT 4 0.0007
467 BREAST MASS 5 0.0007
468 BRUXISM 4 0.0007
469 MUSCLE DISORDER 6 0.0007
470 THERAPY CESSATION 38 0.0007
471 CHEST PAIN 137 0.0007
472 INTENTIONAL DOSE OMISSION 21 0.0007
473 ASPHYXIA 6 0.0007
474 DRUG ERUPTION 13 0.0007
475 CORONARY ARTERY DISEASE 22 0.0007
476 PULMONARY EMBOLISM 69 0.0007
477 LARGE INTESTINE POLYP 5 0.0007
478 FOOT DEFORMITY 8 0.0007
479 HYPOAESTHESIA 108 0.0007
480 EAR PAIN 14 0.0007
481 LARGE INTESTINE PERFORATION 5 0.0007
482 EOSINOPHIL COUNT INCREASED 6 0.0007
483 HYPERTENSIVE CRISIS 8 0.0007
484 NECROSIS 4 0.0007
485 BLOOD UREA INCREASED 12 0.0007
486 ADVERSE DRUG REACTION 64 0.0007
487 LIGAMENT SPRAIN 7 0.0007
488 SEASONAL ALLERGY 10 0.0007
489 CARDIAC DISORDER 66 0.0007
490 THERMAL BURN 5 0.0007
491 BLOOD PRESSURE ABNORMAL 14 0.0007
492 INTERNAL HAEMORRHAGE 8 0.0007
493 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 126 0.0007
494 MUSCULOSKELETAL STIFFNESS 61 0.0007
495 HERPES ZOSTER 40 0.0007
496 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
497 SKIN SWELLING 6 0.0007
498 BONE CANCER 3 0.0007
499 BEDRIDDEN 9 0.0007
500 PRODUCT PREPARATION ERROR 14 0.0007
501 BLINDNESS TRANSIENT 5 0.0007
502 PSYCHIATRIC SYMPTOM 5 0.0007
503 GLAUCOMA 13 0.0007
504 VENTRICULAR EXTRASYSTOLES 7 0.0007
505 CHEST DISCOMFORT 69 0.0007
506 FACIAL PAIN 6 0.0007
507 HAEMARTHROSIS 6 0.0007
508 ROAD TRAFFIC ACCIDENT 28 0.0007
509 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
510 PLASMA CELL MYELOMA 26 0.0007
511 RED BLOOD CELL COUNT DECREASED 19 0.0007
512 TENDON PAIN 5 0.0007
513 BRAIN NEOPLASM 6 0.0007
514 PROCEDURAL COMPLICATION 5 0.0007
515 INJECTION SITE BRUISING 52 0.0007
516 MENISCUS INJURY 4 0.0006
517 DEAFNESS 17 0.0006
518 IRON DEFICIENCY ANAEMIA 6 0.0006
519 PIGMENTATION DISORDER 4 0.0006
520 SKIN LACERATION 7 0.0006
521 BLOOD CHOLESTEROL INCREASED 30 0.0006
522 PRODUCT ADMINISTRATION ERROR 13 0.0006
523 IMPAIRED HEALING 21 0.0006
524 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
525 COLITIS MICROSCOPIC 3 0.0006
526 GAMMA-GLUTAMYLTRANSFERASE INCREASED 14 0.0006
527 MUSCLE ATROPHY 8 0.0006
528 PNEUMOTHORAX 10 0.0006
529 CYSTITIS 20 0.0006
530 COLD SWEAT 11 0.0006
531 DISCOMFORT 38 0.0006
532 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 126 0.0006
533 HEAD DISCOMFORT 11 0.0006
534 STENT PLACEMENT 5 0.0006
535 MYASTHENIA GRAVIS 5 0.0006
536 HEPATIC FUNCTION ABNORMAL 23 0.0006
537 DECUBITUS ULCER 5 0.0006
538 NODULE 8 0.0006
539 JOINT STIFFNESS 16 0.0006
540 TINNITUS 28 0.0006
541 VERTIGO 37 0.0006
542 PELVIC PAIN 11 0.0006
543 OFF LABEL USE 528 0.0006
544 PNEUMONIA 195 0.0006
545 BLOOD PRESSURE INCREASED 92 0.0006
546 INTERSTITIAL LUNG DISEASE 29 0.0006
547 TERMINAL STATE 4 0.0006
548 GAIT DISTURBANCE 114 0.0006
549 INFLUENZA LIKE ILLNESS 49 0.0006
550 LYMPHADENOPATHY 21 0.0006
551 HYPOTHERMIA 6 0.0006
552 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
553 PRODUCT PRESCRIBING ERROR 14 0.0006
554 NEUTROPHIL COUNT INCREASED 6 0.0006
555 RASH ERYTHEMATOUS 28 0.0006
556 HYPERTENSION 124 0.0006
557 CEREBRAL ISCHAEMIA 3 0.0006
558 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 28 0.0006
559 CONTUSION 56 0.0006
560 JOINT EFFUSION 4 0.0006
561 NEURALGIA 14 0.0006
562 TENDERNESS 6 0.0006
563 ORAL DISCOMFORT 8 0.0006
564 CELLULITIS 29 0.0006
565 HEART RATE IRREGULAR 13 0.0006
566 APLASTIC ANAEMIA 3 0.0006
567 ACCIDENTAL EXPOSURE TO PRODUCT 59 0.0006
568 CARPAL TUNNEL SYNDROME 8 0.0006
569 BLOOD LACTIC ACID INCREASED 3 0.0006
570 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
571 SKIN REACTION 8 0.0006
572 PAPULE 4 0.0006
573 DUODENAL ULCER 4 0.0006
574 LYMPHOCYTE COUNT DECREASED 10 0.0006
575 CHOKING 11 0.0006
576 MUSCULAR WEAKNESS 64 0.0006
577 BREAST PAIN 6 0.0006
578 PAIN 344 0.0006
579 MYOSITIS 5 0.0006
580 OROPHARYNGEAL DISCOMFORT 5 0.0006
581 BACK INJURY 6 0.0006
582 OPTIC NEURITIS 5 0.0005
583 ASPIRATION 6 0.0005
584 MAJOR DEPRESSION 4 0.0005
585 MOUTH HAEMORRHAGE 4 0.0005
586 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
587 UROSEPSIS 5 0.0005
588 BLOOD PRESSURE FLUCTUATION 13 0.0005
589 HYPOPHOSPHATAEMIA 4 0.0005
590 ALOPECIA 106 0.0005
591 DIPLOPIA 14 0.0005
592 PRODUCT DISTRIBUTION ISSUE 5 0.0005
593 RESPIRATORY DISORDER 16 0.0005
594 HYDRONEPHROSIS 4 0.0005
595 IMMUNE SYSTEM DISORDER 7 0.0005
596 GASTRIC ULCER 10 0.0005
597 BREAST CANCER 49 0.0005
598 CHOLECYSTECTOMY 6 0.0005
599 DIZZINESS 261 0.0005
600 NEPHROLITHIASIS 24 0.0005
601 GASTROOESOPHAGEAL REFLUX DISEASE 42 0.0005
602 MUSCLE TWITCHING 12 0.0005
603 BLOOD URIC ACID INCREASED 3 0.0005
604 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27 0.0005
605 CONCUSSION 4 0.0005
606 URINARY TRACT INFECTION 88 0.0005
607 APHTHOUS ULCER 4 0.0005
608 HYPOALBUMINAEMIA 4 0.0005
609 GASTROINTESTINAL DISORDER 46 0.0005
610 ORAL HERPES 10 0.0005
611 BALANCE DISORDER 44 0.0005
612 LABORATORY TEST ABNORMAL 15 0.0005
613 DEPRESSED LEVEL OF CONSCIOUSNESS 20 0.0005
614 BACTERAEMIA 6 0.0005
615 JOINT SWELLING 61 0.0005
616 DYSARTHRIA 19 0.0005
617 PROCEDURAL PAIN 14 0.0005
618 RENAL CYST 4 0.0005
619 MACULAR DEGENERATION 6 0.0005
620 CARDIO-RESPIRATORY ARREST 21 0.0005
621 OEDEMA PERIPHERAL 61 0.0005
622 SYNCOPE 50 0.0005
623 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
624 DEVICE DIFFICULT TO USE 33 0.0005
625 BLOOD TEST ABNORMAL 7 0.0005
626 MUSCULOSKELETAL PAIN 26 0.0005
627 COVID-19 87 0.0005
628 EXTRA DOSE ADMINISTERED 20 0.0005
629 TASTE DISORDER 10 0.0005
630 DRY THROAT 5 0.0005
631 ORAL PAIN 11 0.0005
632 CARDIAC FAILURE CONGESTIVE 39 0.0005
633 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
634 TEMPERATURE INTOLERANCE 5 0.0005
635 INFLAMMATION 25 0.0005
636 HYPERTHYROIDISM 7 0.0005
637 GASTRIC CANCER 12 0.0005
638 HALLUCINATION, VISUAL 10 0.0005
639 INCONTINENCE 5 0.0005
640 URINARY INCONTINENCE 14 0.0005
641 THROMBOSIS 38 0.0005
642 HYPOTHYROIDISM 15 0.0005
643 IMMUNODEFICIENCY 7 0.0005
644 CHILLS 55 0.0005
645 DIVERTICULITIS 13 0.0005
646 RASH 203 0.0005
647 HERNIA 9 0.0005
648 SWELLING FACE 30 0.0005
649 FEELING ABNORMAL 110 0.0005
650 INSOMNIA 122 0.0005
651 SARS-COV-2 TEST POSITIVE 6 0.0005
652 IMMUNOSUPPRESSION 4 0.0005
653 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
654 ASPARTATE AMINOTRANSFERASE INCREASED 24 0.0005
655 HOT FLUSH 34 0.0005
656 OCULAR DISCOMFORT 5 0.0004
657 EYE INFECTION 5 0.0004
658 AGEUSIA 11 0.0004
659 CORONARY ARTERY OCCLUSION 6 0.0004
660 PERIPHERAL COLDNESS 6 0.0004
661 BLOOD PRESSURE DECREASED 29 0.0004
662 NEOPLASM 5 0.0004
663 OVARIAN CANCER 4 0.0004
664 BLOOD POTASSIUM DECREASED 13 0.0004
665 RHEUMATOID ARTHRITIS 49 0.0004
666 BLOOD POTASSIUM INCREASED 7 0.0004
667 MIGRAINE 41 0.0004
668 BURNING SENSATION 30 0.0004
669 HYPERKALAEMIA 15 0.0004
670 CHOLELITHIASIS 14 0.0004
671 HYPONATRAEMIA 24 0.0004
672 HEPATIC CIRRHOSIS 8 0.0004
673 EYE PAIN 24 0.0004
674 SLEEP APNOEA SYNDROME 8 0.0004
675 POLYNEUROPATHY 5 0.0004
676 MENTAL DISORDER 18 0.0004
677 INJECTION SITE HAEMATOMA 6 0.0004
678 EAR INFECTION 11 0.0004
679 NASOPHARYNGITIS 76 0.0004
680 HYPOKALAEMIA 19 0.0004
681 PHARYNGEAL SWELLING 4 0.0004
682 ALANINE AMINOTRANSFERASE INCREASED 25 0.0004
683 VITREOUS FLOATERS 4 0.0004
684 THERAPY CHANGE 4 0.0004
685 LIVER DISORDER 18 0.0004
686 OEDEMA 22 0.0004
687 ARTHROPOD BITE 3 0.0004
688 DISABILITY 8 0.0004
689 GENERALISED OEDEMA 5 0.0004
690 INFLUENZA 45 0.0004
691 CYST 5 0.0004
692 THERAPEUTIC PRODUCT EFFECT DECREASED 18 0.0004
693 OVARIAN CYST 4 0.0004
694 EOSINOPHILIA 7 0.0004
695 FATIGUE 309 0.0004
696 PLEURAL EFFUSION 24 0.0004
697 LIP SWELLING 13 0.0004
698 DEVICE RELATED INFECTION 6 0.0004
699 DEATH 333 0.0004
700 PULMONARY HYPERTENSION 8 0.0004
701 PLATELET COUNT INCREASED 5 0.0004
702 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
703 MOUTH ULCERATION 8 0.0004
704 HAEMATURIA 13 0.0004
705 PRODUCT DOSE OMISSION ISSUE 111 0.0004
706 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
707 OBESITY 6 0.0004
708 DYSPHONIA 22 0.0004
709 EATING DISORDER 8 0.0004
710 DELIRIUM 13 0.0004
711 BLOOD DISORDER 3 0.0004
712 SENSORY DISTURBANCE 6 0.0004
713 NIGHT SWEATS 12 0.0004
714 PHOTOPHOBIA 7 0.0004
715 RASH MACULAR 13 0.0004
716 HYPOACUSIS 16 0.0004
717 HAEMOGLOBIN DECREASED 38 0.0004
718 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
719 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
720 MELAENA 8 0.0004
721 ECZEMA 19 0.0004
722 EPILEPSY 11 0.0004
723 NERVE INJURY 4 0.0004
724 POLLAKIURIA 15 0.0004
725 FEELING COLD 10 0.0004
726 APHONIA 5 0.0004
727 NEUROPATHY PERIPHERAL 34 0.0004
728 RASH PAPULAR 8 0.0004
729 PRURITUS 137 0.0004
730 SWELLING 33 0.0004
731 DEHYDRATION 47 0.0004
732 DERMATITIS CONTACT 4 0.0004
733 SCAB 4 0.0004
734 MICTURITION URGENCY 4 0.0003
735 CARDIAC OPERATION 3 0.0003
736 TACHYCARDIA 31 0.0003
737 BLOOD MAGNESIUM DECREASED 3 0.0003
738 METASTASES TO LUNG 4 0.0003
739 ABDOMINAL DISTENSION 36 0.0003
740 VASCULITIS 4 0.0003
741 HEART RATE INCREASED 34 0.0003
742 GASTROENTERITIS 5 0.0003
743 ANGIOEDEMA 15 0.0003
744 COVID-19 PNEUMONIA 4 0.0003
745 SKIN HAEMORRHAGE 5 0.0003
746 BLOOD IRON DECREASED 4 0.0003
747 PULMONARY OEDEMA 15 0.0003
748 OROPHARYNGEAL PAIN 31 0.0003
749 EYE DISORDER 11 0.0003
750 THERAPEUTIC RESPONSE UNEXPECTED 15 0.0003
751 ANAL INCONTINENCE 3 0.0003
752 THROAT TIGHTNESS 9 0.0003
753 APHASIA 10 0.0003
754 VIRAL INFECTION 11 0.0003
755 RESTLESS LEGS SYNDROME 6 0.0003
756 FIBROMYALGIA 8 0.0003
757 MALAISE 144 0.0003
758 FEELING HOT 20 0.0003
759 ASTHENIA 122 0.0003
760 NASAL CONGESTION 19 0.0003
761 VISUAL IMPAIRMENT 40 0.0003
762 RENAL DISORDER 15 0.0003
763 EJECTION FRACTION DECREASED 5 0.0003
764 WEIGHT INCREASED 72 0.0003
765 HAIR COLOUR CHANGES 4 0.0003
766 COGNITIVE DISORDER 15 0.0003
767 PYREXIA 111 0.0003
768 BASAL CELL CARCINOMA 5 0.0003
769 DECREASED APPETITE 74 0.0003
770 DYSPHAGIA 30 0.0003
771 WEIGHT DECREASED 87 0.0003
772 ANAPHYLACTIC SHOCK 8 0.0003
773 HYPOGLYCAEMIA 15 0.0003
774 NEEDLE ISSUE 9 0.0003
775 VISION BLURRED 42 0.0003
776 INCORRECT DOSE ADMINISTERED BY DEVICE 8 0.0003
777 GASTRITIS 8 0.0003
778 SINUSITIS 31 0.0003
779 BRADYCARDIA 16 0.0003
780 MALIGNANT MELANOMA 4 0.0003
781 JOINT RANGE OF MOTION DECREASED 4 0.0003
782 CANDIDA INFECTION 5 0.0003
783 HEMIPARESIS 5 0.0003
784 BODY TEMPERATURE INCREASED 6 0.0003
785 CIRCULATORY COLLAPSE 5 0.0003
786 SCAR 5 0.0003
787 SKIN LESION 8 0.0003
788 DYSPNOEA 163 0.0003
789 ORTHOSTATIC HYPOTENSION 5 0.0003
790 HAEMOPTYSIS 8 0.0003
791 WOUND 8 0.0003
792 SEIZURE 33 0.0003
793 BLINDNESS UNILATERAL 4 0.0003
794 ERYTHEMA 58 0.0003
795 SYSTEMIC LUPUS ERYTHEMATOSUS 10 0.0003
796 THIRST 5 0.0003
797 IRRITABLE BOWEL SYNDROME 6 0.0003
798 LIVER FUNCTION TEST INCREASED 6 0.0003
799 HYPERSOMNIA 8 0.0003
800 SKIN CANCER 6 0.0003
801 CARDIAC ARREST 23 0.0003
802 NAUSEA 220 0.0003
803 PANCREATIC CARCINOMA 8 0.0003
804 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
805 GENERAL PHYSICAL HEALTH DETERIORATION 32 0.0003
806 MYELODYSPLASTIC SYNDROME 4 0.0003
807 HYPOKINESIA 4 0.0003
808 PRODUCT DISPENSING ERROR 6 0.0003
809 HEPATITIS 7 0.0003
810 ABDOMINAL PAIN UPPER 56 0.0003
811 INCORRECT DOSE ADMINISTERED 62 0.0003
812 CARDIOMYOPATHY 4 0.0003
813 OESOPHAGEAL CARCINOMA 8 0.0003
814 URINARY RETENTION 9 0.0003
815 CONJUNCTIVITIS 5 0.0003
816 HYPERSENSITIVITY 50 0.0003
817 SLEEP DISORDER 19 0.0003
818 GLOSSODYNIA 6 0.0003
819 SNEEZING 6 0.0003
820 SPEECH DISORDER 14 0.0003
821 DYSPNOEA EXERTIONAL 10 0.0003
822 ASTHMA 30 0.0003
823 INTESTINAL OBSTRUCTION 10 0.0003
824 HEPATIC ENZYME INCREASED 18 0.0003
825 STOMATITIS 16 0.0003
826 LETHARGY 15 0.0003
827 DRY EYE 13 0.0003
828 ANAEMIA 49 0.0003
829 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 12 0.0003
830 HEART RATE DECREASED 9 0.0003
831 FLUID RETENTION 13 0.0003
832 ANAPHYLACTIC REACTION 14 0.0003
833 SINUS DISORDER 5 0.0003
834 DISORIENTATION 10 0.0003
835 ULCER 4 0.0003
836 CHRONIC KIDNEY DISEASE 19 0.0002
837 HEPATIC CANCER 6 0.0002
838 MOVEMENT DISORDER 8 0.0002
839 DRUG INTOLERANCE 24 0.0002
840 PANIC ATTACK 9 0.0002
841 AMNESIA 16 0.0002
842 RESTLESSNESS 9 0.0002
843 CARDIOMEGALY 3 0.0002
844 BRONCHITIS 18 0.0002
845 CONSTIPATION 53 0.0002
846 COUGH 68 0.0002
847 EYE SWELLING 9 0.0002
848 PERITONITIS 5 0.0002
849 COAGULOPATHY 4 0.0002
850 BRAIN OEDEMA 3 0.0002
851 COLITIS 9 0.0002
852 TREMOR 39 0.0002
853 SKIN ULCER 6 0.0002
854 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
855 ABDOMINAL DISCOMFORT 38 0.0002
856 RENAL FAILURE 30 0.0002
857 EYE IRRITATION 13 0.0002
858 SWOLLEN TONGUE 7 0.0002
859 GALLBLADDER DISORDER 4 0.0002
860 DYSPEPSIA 22 0.0002
861 PRODUCT AVAILABILITY ISSUE 5 0.0002
862 SHOCK 5 0.0002
863 TREATMENT FAILURE 18 0.0002
864 DRUG DOSE OMISSION BY DEVICE 17 0.0002
865 RHINORRHOEA 14 0.0002
866 PERICARDIAL EFFUSION 5 0.0002
867 HEPATIC STEATOSIS 4 0.0002
868 BACTERIAL INFECTION 4 0.0002
869 OXYGEN SATURATION DECREASED 12 0.0002
870 INJURY 15 0.0002
871 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
872 NERVOUSNESS 11 0.0002
873 BRONCHOSPASM 3 0.0002
874 SKIN DISORDER 7 0.0002
875 DRY MOUTH 17 0.0002
876 HYPOTENSION 42 0.0002
877 INCREASED APPETITE 4 0.0002
878 EYE PRURITUS 7 0.0002
879 ANOSMIA 3 0.0002
880 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
881 KIDNEY INFECTION 4 0.0002
882 DEVICE USE ERROR 7 0.0002
883 INFECTION 29 0.0002
884 LACRIMATION INCREASED 6 0.0002
885 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
886 ABDOMINAL PAIN LOWER 5 0.0002
887 ANXIETY 56 0.0002
888 BLINDNESS 8 0.0002
889 BLISTER 11 0.0002
890 HYPOPHAGIA 5 0.0002
891 FLATULENCE 11 0.0002
892 WHITE BLOOD CELL COUNT DECREASED 21 0.0002
893 DRUG-INDUCED LIVER INJURY 6 0.0002
894 OCULAR HYPERAEMIA 9 0.0002
895 VOMITING 89 0.0002
896 DEPRESSED MOOD 10 0.0002
897 MULTIPLE SCLEROSIS 9 0.0002
898 INJECTION SITE HAEMORRHAGE 15 0.0002
899 EPISTAXIS 14 0.0002
900 HYPERHIDROSIS 24 0.0002
901 POOR QUALITY SLEEP 4 0.0002
902 PAIN OF SKIN 5 0.0002
903 FAECES DISCOLOURED 4 0.0002
904 PALLOR 5 0.0002
905 DIABETES MELLITUS 14 0.0002
906 LUNG DISORDER 9 0.0002
907 PRODUCT PRESCRIBING ISSUE 4 0.0002
908 HAEMORRHAGE 19 0.0002
909 RESPIRATORY ARREST 5 0.0002
910 FUNGAL INFECTION 6 0.0002
911 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
912 PANCYTOPENIA 10 0.0002
913 PLATELET COUNT DECREASED 19 0.0002
914 GASTRIC DISORDER 6 0.0002
915 PSORIATIC ARTHROPATHY 7 0.0002
916 DIARRHOEA 111 0.0002
917 INTENTIONAL PRODUCT MISUSE 15 0.0002
918 SEPSIS 19 0.0002
919 PANCREATITIS 9 0.0002
920 BLOOD CREATININE INCREASED 11 0.0002
921 RENAL CANCER 8 0.0002
922 FLUSHING 17 0.0002
923 RESPIRATORY FAILURE 12 0.0002
924 ACUTE KIDNEY INJURY 25 0.0002
925 HAEMATOCHEZIA 9 0.0002
926 BLOOD GLUCOSE ABNORMAL 3 0.0002
927 MEMORY IMPAIRMENT 22 0.0002
928 HAEMATEMESIS 4 0.0002
929 HAEMATOMA 4 0.0002
930 DEPRESSION 35 0.0002
931 RESPIRATORY TRACT INFECTION 4 0.0002
932 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
933 DRUG INEFFECTIVE 196 0.0001
934 JAUNDICE 4 0.0001
935 BLOOD GLUCOSE INCREASED 28 0.0001
936 BLOOD BILIRUBIN INCREASED 4 0.0001
937 DEVICE BREAKAGE 6 0.0001
938 HALLUCINATION 11 0.0001
939 CONDITION AGGRAVATED 44 0.0001
940 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
941 CRYING 5 0.0001
942 ABDOMINAL PAIN 32 0.0001
943 BLADDER CANCER 8 0.0001
944 WHEEZING 8 0.0001
945 DYSGEUSIA 10 0.0001
946 COLITIS ULCERATIVE 6 0.0001
947 SOMNOLENCE 27 0.0001
948 THROAT IRRITATION 6 0.0001
949 CHROMATURIA 3 0.0001
950 SKIN DISCOLOURATION 6 0.0001
951 CONFUSIONAL STATE 21 0.0001
952 DISTURBANCE IN ATTENTION 7 0.0001
953 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
954 DRY SKIN 17 0.0001
955 PRODUCTIVE COUGH 6 0.0001
956 DYSKINESIA 5 0.0001
957 DEVICE ISSUE 11 0.0001
958 TYPE 2 DIABETES MELLITUS 4 0.0001
959 SKIN EXFOLIATION 10 0.0001
960 NIGHTMARE 4 0.0001
961 APPLICATION SITE ERYTHEMA 3 0.0001
962 TREATMENT NONCOMPLIANCE 6 0.0001
963 SKIN IRRITATION 5 0.0001
964 DYSURIA 4 0.0001
965 DISEASE RECURRENCE 5 0.0001
966 COMA 5 0.0001
967 NEUTROPHIL COUNT DECREASED 4 0.0001
968 RHABDOMYOLYSIS 4 0.0001
969 RECTAL HAEMORRHAGE 4 0.0001
970 ACNE 7 0.0001
971 SEPTIC SHOCK 4 0.0001
972 SUICIDAL IDEATION 8 0.0001
973 SKIN BURNING SENSATION 6 0.0001
974 THERAPEUTIC RESPONSE DECREASED 5 0.0001
975 SUICIDE ATTEMPT 5 0.0001
976 ABNORMAL BEHAVIOUR 3 0.0001
977 PRODUCT USE ISSUE 14 0.0001
978 PSORIASIS 9 0.0001
979 AGITATION 5 0.0001
980 PROSTATE CANCER 5 0.0001
981 PRODUCT USE IN UNAPPROVED INDICATION 15 0.0001
982 AGGRESSION 3 0.0001
983 EMOTIONAL DISTRESS 7 0.0001
984 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
985 DRUG INTERACTION 9 0.0001
986 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
987 PRODUCT QUALITY ISSUE 5 0.0000
988 NEUTROPENIA 5 0.0000
989 COMPLETED SUICIDE 3 0.0000
990 THROMBOCYTOPENIA 4 0.0000
991 DISEASE PROGRESSION 4 0.0000
992 NO ADVERSE EVENT 4 0.0000